Skip to content
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics
Breast implants
Dermal reconstruction
Nevelia
Nevelia Pro
Surgical procedure
Clinical cases
Clinical data publications
Live webinars
Videos
Brochures
Black and Black Surgical
Administration systems
B2B administration systems
administration systems SD products
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Linkedin-in
Youtube
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Menu
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
Solutions
Therapeutics
Aesthetics
Administration systems
Impact
CSR commitments and objectives
Symatese Foundation
Symatese Charters
News
Careers
Contact
Who are we
At a glance
Our mission, promise and values
Our story
Global presence and locations
Executive Leadership
Science
Science based
Research and development
SOLUTIONS
Therapeutics
AESTHETICS
Aesthethics
Dermal Fillers
Breast Implants
Dermal Reconstruction
Nevelia
Nevelia Pro
Black and black surgical
Administration systems
Administration systems
B2B Administration systems
Administration system SD products
IMPACT
CSR commitments and objectives
Symatese Foundation
Symatese Charters
NEWS
View our latests news
CAREERS
View open positions
CONTACT
Get in touch
News
1st class III product under MDR CE marking
March 19, 2024
EVOLUS talks about its partnership with SYMATESE at IMCAS
March 1, 2024
IMCAS 2024: what a success for SYMATESE!
February 15, 2024
SYMATESE takes over GROUPE SEBBIN
February 1, 2024
SYMATESE: discover our strong presence at IMCAS 2024
January 18, 2024
SYMATESE DEVICE is at PHARMAPACK 2024
January 18, 2024
More good news from SYMATESE to jump into 2024
December 22, 2023
SYMATESE enters into exclusive Licensing Agreement with EVOLUS
December 20, 2023
The effectiveness of COLLAPATII® in pediatrics
November 21, 2023
SYMATESE GROUP: takeover of SEBBIN GROUP
October 27, 2023
SYMATESE DEVICE awarded by France Relance
October 10, 2023
SUCCESSFUL EVENT AT EBA FOR SYMATESE
September 14, 2023